China Nepstar – hostage to state pricing

Background:Headquartered in Shenzhen, China Nepstar Chain Drugstore (NPD:NYSE), is China's largest pharmaceutical chain with 2,559 stores, 40% of which are located in Guangdong province. The company's stores offer prescription and over-the-counter (OTC) pharmaceuticals, nutritional supplements and Chinese herbal medicine.

China Confidential Funds

China Confidential Funds, a new research service launched by FT China Confidential, is dedicated to illuminating the mainland fund industry. Our team of fund industry experts in Shanghai search out the interesting trends in fund performance, strategy, interactions with overseas funds, regulatory changes, distribution and management. We also use a proprietary system to track the emerging flows of Chinese money. Click here to find out more.

Other Articles on this Issue

• Financial China

  Select financial charts

  Defusing time bombs

• Macro View

  A double dip?

• Funds Data

  China flows hold firm

• The Best of Chinese Commentators

  Convergence of interests

  Uncertainties ahead

• The Big Call

  Trade: a profit-poor boom

• Consumer China

  Healthcare services – breaking free from the state

  Topchoice – the only domestic listed dental clinic

  Aier – focusing on eye care

  Sinopharm – good grounding

• Capital Intensive China

  A slow charge

• Guest Column

  A basket solution

• View issue